These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 32386193)

  • 1. Glucagon-like peptide 1 reverses myocardial hypertrophy through cAMP/PKA/RhoA/ROCK2 signaling.
    Fan S; Xiong Q; Zhang X; Zhang L; Shi Y
    Acta Biochim Biophys Sin (Shanghai); 2020 Jun; 52(6):612-619. PubMed ID: 32386193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GLP-1 attenuates Ang II-induced proliferation and migration in rat aorta smooth muscle cells
    Xiong QF; Fan SH; Zhang X; Niu Y; Li XW; Shi YW; Zhang LH
    Pharmazie; 2018 Dec; 73(12):692-699. PubMed ID: 30522551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipeptidyl Peptidase 4 Inhibition Alleviates Shortage of Circulating Glucagon-Like Peptide-1 in Heart Failure and Mitigates Myocardial Remodeling and Apoptosis via the Exchange Protein Directly Activated by Cyclic AMP 1/Ras-Related Protein 1 Axis.
    Aoyama M; Kawase H; Bando YK; Monji A; Murohara T
    Circ Heart Fail; 2016 Jan; 9(1):e002081. PubMed ID: 26721911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-like peptide-1 attenuates cardiac hypertrophy via the AngII/AT1R/ACE2 and AMPK/mTOR/p70S6K pathways.
    Wang J; Fan S; Xiong Q; Niu Y; Zhang X; Qin J; Shi Y; Zhang L
    Acta Biochim Biophys Sin (Shanghai); 2021 Aug; 53(9):1189-1197. PubMed ID: 34357376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho-dependent mechanism.
    Wang D; Luo P; Wang Y; Li W; Wang C; Sun D; Zhang R; Su T; Ma X; Zeng C; Wang H; Ren J; Cao F
    Diabetes; 2013 May; 62(5):1697-708. PubMed ID: 23364453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide-1 attenuates endothelial barrier injury in diabetes via cAMP/PKA mediated down-regulation of MLC phosphorylation.
    Tang ST; Tang HQ; Su H; Wang Y; Zhou Q; Zhang Q; Wang Y; Zhu HQ
    Biomed Pharmacother; 2019 May; 113():108667. PubMed ID: 30852419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon-like peptide 1 potentiates glucotoxicity-diminished insulin secretion via stimulation of cAMP-PKA signaling in INS-1E cells and mouse islets.
    Luo G; Kong X; Lu L; Xu X; Wang H; Ma X
    Int J Biochem Cell Biol; 2013 Feb; 45(2):483-90. PubMed ID: 23220045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism.
    Liu L; Liu J; Wong WT; Tian XY; Lau CW; Wang YX; Xu G; Pu Y; Zhu Z; Xu A; Lam KS; Chen ZY; Ng CF; Yao X; Huang Y
    Hypertension; 2012 Sep; 60(3):833-41. PubMed ID: 22868389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RhoA activation in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats.
    Moriki N; Ito M; Seko T; Kureishi Y; Okamoto R; Nakakuki T; Kongo M; Isaka N; Kaibuchi K; Nakano T
    Hypertens Res; 2004 Apr; 27(4):263-70. PubMed ID: 15127884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alarin moderated myocardial hypertrophy via inhibiting cyclic adenosine monophosphate/protein kinase A signaling pathway to attenuate autophagy.
    Shen T; Liu Y; Dong S; Xu X; Wang X; Li Y; Zhou L
    Peptides; 2021 Dec; 146():170669. PubMed ID: 34624429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-like peptide 1 treatment reverses vascular remodelling by downregulating matrix metalloproteinase 1 expression through inhibition of the ERK1/2/NF-κB signalling pathway.
    Fan SH; Xiong QF; Wang L; Zhang LH; Shi YW
    Mol Cell Endocrinol; 2020 Dec; 518():111005. PubMed ID: 32877753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.
    Oeseburg H; de Boer RA; Buikema H; van der Harst P; van Gilst WH; Silljé HH
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1407-14. PubMed ID: 20448207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exendin-4 alleviates angiotensin II-induced senescence in vascular smooth muscle cells by inhibiting Rac1 activation via a cAMP/PKA-dependent pathway.
    Zhao L; Li AQ; Zhou TF; Zhang MQ; Qin XM
    Am J Physiol Cell Physiol; 2014 Dec; 307(12):C1130-41. PubMed ID: 25298426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-like peptide 1 stimulates insulin secretion via inhibiting RhoA/ROCK signaling and disassembling glucotoxicity-induced stress fibers.
    Kong X; Yan D; Sun J; Wu X; Mulder H; Hua X; Ma X
    Endocrinology; 2014 Dec; 155(12):4676-85. PubMed ID: 25243854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipeptidyl peptidase IV inhibition upregulates GLUT4 translocation and expression in heart and skeletal muscle of spontaneously hypertensive rats.
    Giannocco G; Oliveira KC; Crajoinas RO; Venturini G; Salles TA; Fonseca-Alaniz MH; Maciel RM; Girardi AC
    Eur J Pharmacol; 2013 Jan; 698(1-3):74-86. PubMed ID: 23051671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuated diuresis and natriuresis in response to glucagon-like peptide-1 in hypertensive rats are associated with lower expression of the glucagon-like peptide-1 receptor in the renal vasculature.
    Savignano FA; Crajoinas RO; Pacheco BPM; Campos LCG; Shimizu MHM; Seguro AC; Girardi ACC
    Eur J Pharmacol; 2017 Sep; 811():38-47. PubMed ID: 28576404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of G protein-coupled estrogen receptor 1 induces coronary artery relaxation via Epac/Rap1-mediated inhibition of RhoA/Rho kinase pathway in parallel with PKA.
    Yu X; Zhang Q; Zhao Y; Schwarz BJ; Stallone JN; Heaps CL; Han G
    PLoS One; 2017; 12(3):e0173085. PubMed ID: 28278256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of pancreatic beta-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways.
    Friedrichsen BN; Neubauer N; Lee YC; Gram VK; Blume N; Petersen JS; Nielsen JH; Møldrup A
    J Endocrinol; 2006 Mar; 188(3):481-92. PubMed ID: 16522728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide-1 protects mesenteric endothelium from injury during inflammation.
    Dozier KC; Cureton EL; Kwan RO; Curran B; Sadjadi J; Victorino GP
    Peptides; 2009 Sep; 30(9):1735-41. PubMed ID: 19560500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced Glycation End Products Impair Ca2+ Mobilization and Sensitization in Colonic Smooth Muscle Cells via the CAMP/PKA Pathway.
    Yu T; Wang Y; Qian D; Sun X; Tang Y; Shen X; Lin L
    Cell Physiol Biochem; 2017; 43(4):1571-1587. PubMed ID: 29035879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.